This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Cornus officinalis is a traditional East Asian medicinal herb used for kidney-tonifying and anti-inflammatory purposes [PMID:40784528, PMID:33912050]. Recent research highlights its potential in treating neurodegenerative, metabolic, and renal disorders [PMID:33912050, PMID:40714074].
Background
Cornus officinalis (Asiatic dogwood) is a deciduous tree distributed in eastern Asia, primarily China, Korea, and Japan [PMID:30210335]. Its ripening and dry fruits, known as Corni Fructus, are essential components of Traditional Chinese Medicine (TCM) [PMID:29983732].
Traditional uses
Traditionally used for nearly two thousand years in TCM to treat dizziness, tinnitus, impotence, spermatorrhea, profuse sweating, and conditions affecting the lumbar and knee regions [PMID:40784528, PMID:29155174]. It is characterized by sour, astringent, and warming properties used to tonify the liver and kidney and nourish the essence [PMID:33912050, PMID:40784528].
Active compounds
Identified bioactive constituents include iridoids (loganin, morroniside, sweroside, cornuside, cornuside I, cornel iridoid glycoside), flavonoids (kaempferol, myricetin, quercetin, trifolin), and verbenalin [PMID:38111697, PMID:39307743, PMID:36628351, PMID:36104266].
Mechanism of action
Mechanisms include attenuation of the NLRP3 inflammasome axis [PMID:39972387, PMID:40490233, PMID:39510640], promotion of mitophagy via Pink1/Parkin signaling [PMID:39972387], activation of the NRF2/HO-1 pathway [PMID:39510640], and regulation of the PI3K/AKT pathway [PMID:40490233, PMID:40432887]. It also modulates gut microbiota to suppress proinflammatory metabolites [PMID:40501499, PMID:38788396].
Clinical evidence
Evidence DCognitive Impairment/Alzheimer's
Cornuside ameliorated behavioral deficits and protected synaptic plasticity by attenuating NLRP3-mediated neurotoxicity and promoting mitophagy in mice [PMID:39972387].
Evidence DAcute Lung Injury (ALI)
Cornus officinalis ethanol extract and loganin attenuated ALI in mice by regulating the PI3K/AKT/NLRP3 axis [PMID:40490233].
Evidence COsteoporosis
Bioactive constituents like morroniside and sweroside are supported as effective in OP treatment [PMID:38111697].
Evidence CDiabetes and Complications
Loganin and morroniside promote insulin secretion and improve insulin resistance; they show potential in treating diabetic nephropathy and neuropathy [PMID:40714074].
Evidence DHyperuricemia
Extracts significantly reduced serum uric acid levels and increased urinary excretion by modulating URAT1 in rat models [PMID:41155274].
Evidence D
Safety & adverse effects
Verbenalin, a compound in C. officinalis, showed no signs of mutagenicity in the Ames test [PMID:36628351]. Some reviews note low toxicity and excellent tolerability for long-term administration [PMID:38111697].
Evidence summary
The evidence is primarily based on in vitro studies and animal models (Level D), with several comprehensive reviews (Level C) summarizing traditional use and phytochemical profiles. There is a lack of high-level human clinical trial data (Level A/B) in the provided abstracts.
PubMed sources
1.PMID: 39972387 (2025) — Cornuside alleviates cognitive impairments induced by Aβ1-42 through attenuating NLRP3-mediated neurotoxicity by promoting mitophagy. · Alzheimer's research & therapy
3.PMID: 30210335 (2018) — Cornus mas and Cornus Officinalis-Analogies and Differences of Two Medicinal Plants Traditionally Used. · Frontiers in pharmacology
4.PMID: 40490233 (2025) — Cornus officinalis loganin attenuates acute lung injury in mice via regulating the PI3K/AKT/NLRP3 axis. · Journal of ethnopharmacology
5.PMID: 38111697 (2023) — Cornus officinalis: a potential herb for treatment of osteoporosis.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
Morroniside delayed NASH progression by promoting AMPK-mediated lipophagy in mice [PMID:38723527].
Evidence DPost-stroke Depression
Morroniside alleviated depression-like behaviors in mice via the BDNF signaling pathway [PMID:38006805].
· Frontiers in medicine
6.PMID: 36628351 (2022) — Bacterial Reverse Mutation Test of Verbenalin. · Journal of pharmacopuncture
7.PMID: 39307743 (2024) — [A new secoiridoid from Cornus officinalis]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
8.PMID: 40784528 (2025) — Cornus officinalis Sieb.: An updated review on the ethnopharmacology, phytochemistry, pharmacology, toxicology, and pharmacokinetics. · Journal of ethnopharmacology
9.PMID: 39510640 (2024) — Loganin inhibits the ROS-NLRP3-IL-1β axis by activating the NRF2/HO-1 pathway against osteoarthritis. · Chinese journal of natural medicines
10.PMID: 33912050 (2021) — Active Components and Pharmacological Effects of Cornus officinalis: Literature Review. · Frontiers in pharmacology
11.PMID: 37579922 (2024) — Rehmannia glutinosa Libosch and Cornus officinalis Sieb herb couple ameliorates renal interstitial fibrosis in CKD rats by inhibiting the TGF-β1/MAPK signaling pathway. · Journal of ethnopharmacology
12.PMID: 38723527 (2024) — Morroniside delays the progression of non-alcoholic steatohepatitis by promoting AMPK-mediated lipophagy. · Phytomedicine : international journal of phytotherapy and phytopharmacology
13.PMID: 29983732 (2018) — Corni Fructus: a review of chemical constituents and pharmacological activities. · Chinese medicine
14.PMID: 29155174 (2018) — Ethnopharmacology, phytochemistry, and pharmacology of Cornus officinalis Sieb. et Zucc. · Journal of ethnopharmacology
15.PMID: 37475719 (2023) — Research progress on Cornus officinalis and its active compounds in the treatment of diabetic nephropathy. · Frontiers in pharmacology
16.PMID: 40661830 (2025) — Cornus officinalis Protects Against Steroid-Induced Osteonecrosis of the Femoral Head Through Inhibiting Inflammatory Responses and Apoptosis via Network Pharmacology and Experimental Validation. · Drug design, development and therapy
17.PMID: 38788396 (2024) — Therapeutic mechanism of Cornus Officinalis Fruit Coreon on ALI by AKT/Nrf2 pathway and gut microbiota. · Phytomedicine : international journal of phytotherapy and phytopharmacology
18.PMID: 41403435 (2025) — Decoding the therapeutic potential mechanism of Cornus officinalis in Parkinson's disease: a network pharmacology insight. · Frontiers in pharmacology
19.PMID: 40714074 (2025) — Loganin and morroniside: Therapeutic effects and molecular mechanisms in diabetes mellitus and its complications-A review. · European journal of pharmacology
20.PMID: 40501499 (2025) — Cornus officinalis Extract Ameliorates Fructose-Induced Hepatic Steatosis in Mice by Sustaining the Homeostasis of Intestinal Microecology and Lipid Metabolism. · Food science & nutrition
21.PMID: 41663651 (2026) — Cornus officinalis extract modulates rumen microbiome and growth of lambs fed a high-concentrate diet. · AMB Express
22.PMID: 40962125 (2026) — Cornuside ameliorates LPS induced cognitive dysfunction and microglial NLRP3 inflammasome activation by enhancing Sirt1-mediated autophagy. · Journal of ethnopharmacology
24.PMID: 36104266 (2022) — Cornel Iridoid Glycoside Alleviates Microglia-Mediated Inflammatory Response via the NLRP3/Calpain Pathway. · Journal of agricultural and food chemistry
25.PMID: 41155274 (2025) — Antihyperuricemic Effects of Cornus officinalis Extract via URAT1 Regulation and Renoprotective Mechanisms. · International journal of molecular sciences
26.PMID: 35592634 (2022) — Optimizing Processing Technology of Cornus officinalis: Based on Anti-Fibrotic Activity. · Frontiers in nutrition
27.PMID: 42178074 (2026) — Combination of Cornus officinalis Siebold and Moutan officinalis (L.) Lindl. alleviates the metabolic disorders of MAFLD through regulating IRE1α/ASK1/JNK pathway mediated endoplasmic reticulum stress. · Journal of ethnopharmacology
28.PMID: 40432887 (2025) — Regulation of autophagy by the PI3K-AKT pathway in Astragalus membranaceus -Cornus officinalis to ameliorate diabetic nephropathy. · Frontiers in pharmacology
29.PMID: 33930987 (2022) — Secoiridoid glycosides from the fruits of Cornus officinalis. · Natural product research
30.PMID: 38006805 (2024) — Morroniside improves the symptoms of post-stroke depression in mice through the BDNF signaling pathway mediated by MiR-409-3p. · Phytomedicine : international journal of phytotherapy and phytopharmacology